TMDX

TransMedics Group (TMDX)

About TransMedics Group (TMDX)

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.

Details

Daily high

$69.67

Daily low

$67.33

Price at open

$68.43

52 Week High

$177.37

52 Week Low

$55.00

Market cap

2.3B

Dividend yield

0.00%

Volume

408,168

Avg. volume

1.4M

P/E ratio

67.84

TransMedics Group News